- Home
- ASBP vs NBY Comparison
ASBP vs NBY Comparison
Compare ASBP & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASBP
- NBY
- Stock Information
- Founded
- ASBP 2021
- NBY 2000
- Country
- ASBP United States
- NBY United States
- Employees
- ASBP N/A
- NBY N/A
- Industry
- ASBP Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- ASBP Health Care
- NBY
- Exchange
- ASBP Nasdaq
- NBY Nasdaq
- Market Cap
- ASBP 18.7M
- NBY 15.7M
- IPO Year
- ASBP N/A
- NBY 2007
- Fundamental
- Price
- ASBP $0.35
- NBY $1.19
- Analyst Decision
- ASBP
- NBY Strong Buy
- Analyst Count
- ASBP 0
- NBY 1
- Target Price
- ASBP N/A
- NBY $0.85
- AVG Volume (30 Days)
- ASBP 39.9M
- NBY 1.2M
- Earning Date
- ASBP 11-24-2025
- NBY 11-06-2025
- Dividend Yield
- ASBP N/A
- NBY N/A
- EPS Growth
- ASBP N/A
- NBY N/A
- EPS
- ASBP N/A
- NBY 0.41
- Revenue
- ASBP N/A
- NBY $9,781,000.00
- Revenue This Year
- ASBP N/A
- NBY $23.91
- Revenue Next Year
- ASBP N/A
- NBY $32.05
- P/E Ratio
- ASBP N/A
- NBY $3.52
- Revenue Growth
- ASBP N/A
- NBY 113.47
- 52 Week Low
- ASBP $0.20
- NBY $0.46
- 52 Week High
- ASBP $15.80
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- ASBP 46.05
- NBY 42.16
- Support Level
- ASBP $0.20
- NBY $1.22
- Resistance Level
- ASBP $0.43
- NBY $1.64
- Average True Range (ATR)
- ASBP 0.06
- NBY 0.22
- MACD
- ASBP -0.00
- NBY -0.17
- Stochastic Oscillator
- ASBP 58.81
- NBY 0.82
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.